{"entity":{"type":"insider","cik":"0001598292","url":"/insider/0001598292","json_url":"/insider/0001598292.json","name":"EcoR1 Capital Fund Qualified, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":13,"first":"2014-03-28","last":"2023-09-22","span_basis":"filed_date"},"name_variants":[{"name":"EcoR1 Capital Fund Qualified, L.P.","source":"filing","n_filings":13,"first_seen":"2014-03-28","last_seen":"2023-09-22"}],"transactions":[{"id":9210424,"accession":"0000935836-23-000621","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000935836-23-000621","line_url":"/filing/0000935836-23-000621#line-3","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Venture Opportunity Fund, LP; NODELMAN OLEG","owner_display_name":"Biotech Opportunity GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53000.0,"shares_display":"53,000","price_per_share":1.3611,"price_display":"1.36","price_state":"stated","total_value":72138.3,"total_display":"72,138.30","total_whole":"72,138","shares_owned_after":12674775.0,"shares_owned_after_display":"12,674,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-22","scope":"insider"},{"id":9210422,"accession":"0000935836-23-000621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000935836-23-000621","line_url":"/filing/0000935836-23-000621#line-2","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Venture Opportunity Fund, LP; NODELMAN OLEG","owner_display_name":"Biotech Opportunity GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117100.0,"shares_display":"117,100","price_per_share":1.362,"price_display":"1.36","price_state":"stated","total_value":159490.2,"total_display":"159,490.20","total_whole":"159,490","shares_owned_after":12621775.0,"shares_owned_after_display":"12,621,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":9210423,"accession":"0000935836-23-000621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-23-000621","line_url":"/filing/0000935836-23-000621#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Venture Opportunity Fund, LP; NODELMAN OLEG","owner_display_name":"Biotech Opportunity GP, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5143000.0,"shares_display":"5,143,000","price_per_share":1.2562,"price_display":"1.26","price_state":"stated","total_value":6460636.6,"total_display":"6,460,636.60","total_whole":"6,460,637","shares_owned_after":12504675.0,"shares_owned_after_display":"12,504,675","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-22","scope":"insider"},{"id":8064090,"accession":"0000935836-23-000619","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000935836-23-000619","line_url":"/filing/0000935836-23-000619#line-3","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; Biotech Opportunity GP, LLC; NODELMAN OLEG; EcoR1 Capital Fund, L.P.; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53000.0,"shares_display":"53,000","price_per_share":1.3611,"price_display":"1.36","price_state":"stated","total_value":72138.3,"total_display":"72,138.30","total_whole":"72,138","shares_owned_after":12674775.0,"shares_owned_after_display":"12,674,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-09-21","scope":"insider"},{"id":8064086,"accession":"0000935836-23-000619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000935836-23-000619","line_url":"/filing/0000935836-23-000619#line-2","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; Biotech Opportunity GP, LLC; NODELMAN OLEG; EcoR1 Capital Fund, L.P.; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117100.0,"shares_display":"117,100","price_per_share":1.362,"price_display":"1.36","price_state":"stated","total_value":159490.2,"total_display":"159,490.20","total_whole":"159,490","shares_owned_after":12621775.0,"shares_owned_after_display":"12,621,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-20","filed_date":"2023-09-21","scope":"insider"},{"id":8064080,"accession":"0000935836-23-000619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000935836-23-000619","line_url":"/filing/0000935836-23-000619#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; Biotech Opportunity GP, LLC; NODELMAN OLEG; EcoR1 Capital Fund, L.P.; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5143000.0,"shares_display":"5,143,000","price_per_share":1.2562,"price_display":"1.26","price_state":"stated","total_value":6460636.6,"total_display":"6,460,636.60","total_whole":"6,460,637","shares_owned_after":12504675.0,"shares_owned_after_display":"12,504,675","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-19","filed_date":"2023-09-21","scope":"insider"},{"id":4907351,"accession":"0001567619-21-021329","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-21-021329","line_url":"/filing/0001567619-21-021329","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; NODELMAN OLEG; Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":185026.0,"shares_display":"185,026","price_per_share":7.6859,"price_display":"7.69","price_state":"stated","total_value":1422091.3334,"total_display":"1,422,091.33","total_whole":"1,422,091","shares_owned_after":7361675.0,"shares_owned_after_display":"7,361,675","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":4907344,"accession":"0001567619-21-021329","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-021329","line_url":"/filing/0001567619-21-021329#line-4","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; NODELMAN OLEG; Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56598.0,"shares_display":"56,598","price_per_share":8.64,"price_display":"8.64","price_state":"stated","total_value":489006.72,"total_display":"489,006.72","total_whole":"489,007","shares_owned_after":1147483.0,"shares_owned_after_display":"1,147,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-31","filed_date":"2021-11-30","scope":"insider"},{"id":4907339,"accession":"0001567619-21-021329","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-021329","line_url":"/filing/0001567619-21-021329#line-3","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; NODELMAN OLEG; Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56598.0,"shares_display":"56,598","price_per_share":8.64,"price_display":"8.64","price_state":"stated","total_value":489006.72,"total_display":"489,006.72","total_whole":"489,007","shares_owned_after":7198407.0,"shares_owned_after_display":"7,198,407","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-31","filed_date":"2021-11-30","scope":"insider"},{"id":4147182,"accession":"0001567619-21-007976","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31500.0,"shares_display":"31,500","price_per_share":10.271,"price_display":"10.27","price_state":"stated","total_value":323536.5,"total_display":"323,536.50","total_whole":"323,537","shares_owned_after":6990265.0,"shares_owned_after_display":"6,990,265","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":4147177,"accession":"0001567619-21-007976","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133000.0,"shares_display":"133,000","price_per_share":9.4878,"price_display":"9.49","price_state":"stated","total_value":1261877.4,"total_display":"1,261,877.40","total_whole":"1,261,877","shares_owned_after":6962731.0,"shares_owned_after_display":"6,962,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":5174495,"accession":"0001213900-21-021365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-021365","line_url":"/filing/0001213900-21-021365#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Panacea Acquisition Corp. II","issuer_ticker":"PANA","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund, L.P.; NODELMAN OLEG; EcoR1 Capital Fund Qualified, L.P.; Biotech Opportunity GP, LLC; EcoR1 Panacea Holdings II, LLC","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Director, Officer (CEO and Chairman of the Board), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":"CEO and Chairman of the Board","security_title":"Class A ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":545000.0,"shares_display":"545,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5450000.0,"total_display":"5,450,000.00","total_whole":"5,450,000","shares_owned_after":545000.0,"shares_owned_after_display":"545,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-09","filed_date":"2021-04-13","scope":"insider"},{"id":4147169,"accession":"0001567619-21-007976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-007976","line_url":"/filing/0001567619-21-007976","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; Biotech Opportunity GP, LLC; EcoR1 Capital, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":10.0306,"price_display":"10.03","price_state":"stated","total_value":3009180.0,"total_display":"3,009,180.00","total_whole":"3,009,180","shares_owned_after":6846476.0,"shares_owned_after_display":"6,846,476","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-09","filed_date":"2021-04-13","scope":"insider","n_lines":2},{"id":4907335,"accession":"0001567619-21-021329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-021329","line_url":"/filing/0001567619-21-021329#line-2","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; NODELMAN OLEG; Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":151544.0,"shares_display":"151,544","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":1583634.8,"total_display":"1,583,634.80","total_whole":"1,583,635","shares_owned_after":1145600.0,"shares_owned_after_display":"1,145,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-11-30","scope":"insider"},{"id":4907330,"accession":"0001567619-21-021329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021329","line_url":"/filing/0001567619-21-021329#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; NODELMAN OLEG; Biotech Opportunity GP, LLC; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":151544.0,"shares_display":"151,544","price_per_share":10.45,"price_display":"10.45","price_state":"stated","total_value":1583634.8,"total_display":"1,583,634.80","total_whole":"1,583,635","shares_owned_after":6735790.0,"shares_owned_after_display":"6,735,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-11-30","scope":"insider"},{"id":3048705,"accession":"0001213900-20-016762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-016762","line_url":"/filing/0001213900-20-016762#line-1","is_derivative":false,"issuer_cik":"0001454385","issuer_name":"Panacea Acquisition Corp","issuer_ticker":"PANA","issuer_name_source":null,"issuer_url":"/issuer/0001454385","owner_cik":null,"owner_name":"EcoR1 Panacea Holdings, LLC; EcoR1 Capital Fund, L.P.; EcoR1 Capital Fund Qualified, L.P.; EcoR1 Venture Opportunity Fund, LP; EcoR1 Capital, LLC; Biotech Opportunity GP, LLC; NODELMAN OLEG","owner_display_name":"EcoR1 Panacea Holdings, LLC","owner_url":null,"role":"Director, Officer (CEO and Chairman of the Board), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":"CEO and Chairman of the Board","security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":390000.0,"shares_display":"390,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3900000.0,"total_display":"3,900,000.00","total_whole":"3,900,000","shares_owned_after":390000.0,"shares_owned_after_display":"390,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-06","filed_date":"2020-07-06","scope":"insider"},{"id":8506663,"accession":"0001567619-19-000984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-000984","line_url":"/filing/0001567619-19-000984#line-4","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83540.0,"shares_display":"83,540","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":1099386.4,"total_display":"1,099,386.40","total_whole":"1,099,386","shares_owned_after":4408097.0,"shares_owned_after_display":"4,408,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2019-01-10","scope":"insider"},{"id":8506658,"accession":"0001567619-19-000984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-19-000984","line_url":"/filing/0001567619-19-000984#line-3","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51879.0,"shares_display":"51,879","price_per_share":13.84,"price_display":"13.84","price_state":"stated","total_value":718005.36,"total_display":"718,005.36","total_whole":"718,005","shares_owned_after":4324557.0,"shares_owned_after_display":"4,324,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2019-01-10","scope":"insider"},{"id":8506651,"accession":"0001567619-19-000984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-000984","line_url":"/filing/0001567619-19-000984#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78469.0,"shares_display":"78,469","price_per_share":13.82,"price_display":"13.82","price_state":"stated","total_value":1084441.58,"total_display":"1,084,441.58","total_whole":"1,084,442","shares_owned_after":4272678.0,"shares_owned_after_display":"4,272,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2019-01-10","scope":"insider"},{"id":8506648,"accession":"0001567619-19-000984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-000984","line_url":"/filing/0001567619-19-000984#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26520.0,"shares_display":"26,520","price_per_share":13.2,"price_display":"13.20","price_state":"stated","total_value":350064.0,"total_display":"350,064.00","total_whole":"350,064","shares_owned_after":4194209.0,"shares_owned_after_display":"4,194,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2019-01-10","scope":"insider"},{"id":5988905,"accession":"0001567619-18-007956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-007956","line_url":"/filing/0001567619-18-007956#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25217.0,"shares_display":"25,217","price_per_share":13.89,"price_display":"13.89","price_state":"stated","total_value":350264.13,"total_display":"350,264.13","total_whole":"350,264","shares_owned_after":4220729.0,"shares_owned_after_display":"4,220,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-13","filed_date":"2018-12-13","scope":"insider"},{"id":5988902,"accession":"0001567619-18-007956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-007956","line_url":"/filing/0001567619-18-007956#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15321.0,"shares_display":"15,321","price_per_share":13.9089,"price_display":"13.91","price_state":"stated","total_value":213098.2569,"total_display":"213,098.26","total_whole":"213,098","shares_owned_after":4195512.0,"shares_owned_after_display":"4,195,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-13","scope":"insider"},{"id":5978397,"accession":"0001567619-18-007453","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-007453","line_url":"/filing/0001567619-18-007453#line-3","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17079.0,"shares_display":"17,079","price_per_share":13.49,"price_display":"13.49","price_state":"stated","total_value":230395.71,"total_display":"230,395.71","total_whole":"230,396","shares_owned_after":4180919.0,"shares_owned_after_display":"4,180,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-06","scope":"insider"},{"id":5978395,"accession":"0001567619-18-007453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-007453","line_url":"/filing/0001567619-18-007453#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54645.0,"shares_display":"54,645","price_per_share":13.08,"price_display":"13.08","price_state":"stated","total_value":714756.6,"total_display":"714,756.60","total_whole":"714,757","shares_owned_after":4163112.0,"shares_owned_after_display":"4,163,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider"},{"id":5978394,"accession":"0001567619-18-007453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-007453","line_url":"/filing/0001567619-18-007453#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48182.0,"shares_display":"48,182","price_per_share":13.97,"price_display":"13.97","price_state":"stated","total_value":673102.54,"total_display":"673,102.54","total_whole":"673,103","shares_owned_after":4108467.0,"shares_owned_after_display":"4,108,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6613086,"accession":"0001140361-18-024271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-024271","line_url":"/filing/0001140361-18-024271#line-3","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2733231.0,"shares_display":"2,733,231","price_per_share":0.8111,"price_display":"0.81","price_state":"stated","total_value":2216923.6641,"total_display":"2,216,923.66","total_whole":"2,216,924","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-16","scope":"insider"},{"id":6613083,"accession":"0001140361-18-024271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-024271","line_url":"/filing/0001140361-18-024271#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121294.0,"shares_display":"121,294","price_per_share":1.4268,"price_display":"1.43","price_state":"stated","total_value":173062.2792,"total_display":"173,062.28","total_whole":"173,062","shares_owned_after":2733231.0,"shares_owned_after_display":"2,733,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider"},{"id":6613080,"accession":"0001140361-18-024271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-024271","line_url":"/filing/0001140361-18-024271#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354791.0,"shares_display":"354,791","price_per_share":1.7167,"price_display":"1.72","price_state":"stated","total_value":609069.7097,"total_display":"609,069.71","total_whole":"609,070","shares_owned_after":2854525.0,"shares_owned_after_display":"2,854,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-16","scope":"insider"},{"id":5075163,"accession":"0001140361-17-046221","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-6","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1083.0,"shares_display":"1,083","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":4277.85,"total_display":"4,277.85","total_whole":"4,278","shares_owned_after":3209316.0,"shares_owned_after_display":"3,209,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-12-14","scope":"insider"},{"id":5075159,"accession":"0001140361-17-046221","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-5","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5860.0,"shares_display":"5,860","price_per_share":4.0008,"price_display":"4.00","price_state":"stated","total_value":23444.688,"total_display":"23,444.69","total_whole":"23,445","shares_owned_after":3210399.0,"shares_owned_after_display":"3,210,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-12-14","scope":"insider"},{"id":5075157,"accession":"0001140361-17-046221","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-4","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5819.0,"shares_display":"5,819","price_per_share":4.1504,"price_display":"4.15","price_state":"stated","total_value":24151.1776,"total_display":"24,151.18","total_whole":"24,151","shares_owned_after":3216259.0,"shares_owned_after_display":"3,216,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-12-14","scope":"insider"},{"id":5075152,"accession":"0001140361-17-046221","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-3","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":4601.0,"total_display":"4,601.00","total_whole":"4,601","shares_owned_after":3222078.0,"shares_owned_after_display":"3,222,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-08","filed_date":"2017-12-14","scope":"insider"},{"id":5075148,"accession":"0001140361-17-046221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24728.0,"shares_display":"24,728","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":118694.4,"total_display":"118,694.40","total_whole":"118,694","shares_owned_after":3223148.0,"shares_owned_after_display":"3,223,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-12-14","scope":"insider"},{"id":5075146,"accession":"0001140361-17-046221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-046221","line_url":"/filing/0001140361-17-046221#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001598292","owner_name":"EcoR1 Capital Fund Qualified, L.P.","owner_display_name":"EcoR1 Capital Fund Qualified, L.P.","owner_url":"/insider/0001598292","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4879.0,"shares_display":"4,879","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":24638.95,"total_display":"24,638.95","total_whole":"24,639","shares_owned_after":3198420.0,"shares_owned_after_display":"3,198,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-01","filed_date":"2017-12-14","scope":"insider"},{"id":6952757,"accession":"0000921895-14-001307","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-14-001307","line_url":"/filing/0000921895-14-001307","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9040.0,"shares_display":"9,040","price_per_share":2.3916,"price_display":"2.39","price_state":"stated","total_value":21620.064,"total_display":"21,620.06","total_whole":"21,620","shares_owned_after":1024358.0,"shares_owned_after_display":"1,024,358","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-27","scope":"insider","n_lines":2},{"id":6952751,"accession":"0000921895-14-001307","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-14-001307","line_url":"/filing/0000921895-14-001307","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4600.0,"shares_display":"4,600","price_per_share":2.1946,"price_display":"2.19","price_state":"stated","total_value":10095.16,"total_display":"10,095.16","total_whole":"10,095","shares_owned_after":1019696.0,"shares_owned_after_display":"1,019,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-23","filed_date":"2014-05-27","scope":"insider","n_lines":2},{"id":6952746,"accession":"0000921895-14-001307","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-14-001307","line_url":"/filing/0000921895-14-001307","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital Fund, L.P.; EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG","owner_display_name":"EcoR1 Capital Fund, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10500.0,"shares_display":"10,500","price_per_share":2.1302,"price_display":"2.13","price_state":"stated","total_value":22367.1,"total_display":"22,367.10","total_whole":"22,367","shares_owned_after":1017324.0,"shares_owned_after_display":"1,017,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider","n_lines":2},{"id":6815416,"accession":"0000921895-14-000680","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-14-000680","line_url":"/filing/0000921895-14-000680","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG; EcoR1 Capital Fund, L.P.","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47515.0,"shares_display":"47,515","price_per_share":2.7328,"price_display":"2.73","price_state":"stated","total_value":129848.992,"total_display":"129,848.99","total_whole":"129,849","shares_owned_after":1176907.0,"shares_owned_after_display":"1,176,907","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-28","filed_date":"2014-03-28","scope":"insider","n_lines":2},{"id":6815409,"accession":"0000921895-14-000680","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-14-000680","line_url":"/filing/0000921895-14-000680","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG; EcoR1 Capital Fund, L.P.","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51215.0,"shares_display":"51,215","price_per_share":2.4923,"price_display":"2.49","price_state":"stated","total_value":127643.1445,"total_display":"127,643.14","total_whole":"127,643","shares_owned_after":1148398.0,"shares_owned_after_display":"1,148,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-27","filed_date":"2014-03-28","scope":"insider","n_lines":2},{"id":6815401,"accession":"0000921895-14-000680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-14-000680","line_url":"/filing/0000921895-14-000680","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":null,"owner_name":"EcoR1 Capital, LLC; EcoR1 Capital Fund Qualified, L.P.; NODELMAN OLEG; EcoR1 Capital Fund, L.P.","owner_display_name":"EcoR1 Capital, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23543.0,"shares_display":"23,543","price_per_share":2.3145,"price_display":"2.31","price_state":"stated","total_value":54490.2735,"total_display":"54,490.27","total_whole":"54,490","shares_owned_after":1117669.0,"shares_owned_after_display":"1,117,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-03-26","filed_date":"2014-03-28","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001811063","name":"Nuvation Bio Inc.","url":"/issuer/0001811063","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2020-07-06","last_seen":"2023-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001828989","name":"Panacea Acquisition Corp. II","url":"/issuer/0001828989","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2021-04-13","last_seen":"2021-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Ten percent owner","n_filings":3,"first_seen":"2018-12-06","last_seen":"2019-01-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Ten percent owner","n_filings":2,"first_seen":"2017-12-14","last_seen":"2018-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000934473","name":"GENVEC INC","url":"/issuer/0000934473","role":"Other","n_filings":2,"first_seen":"2014-03-28","last_seen":"2014-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598292","retrieved_at":"2026-08-23T15:24:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}